<?xml version='1.0' encoding='utf-8'?>
<document id="22943745"><sentence text="Lack of a pharmacokinetic drug-drug interaction between lithium and valproate when co-administered with aripiprazole."><entity charOffset="56-63" id="DDI-PubMed.22943745.s1.e0" text="lithium" /><entity charOffset="68-77" id="DDI-PubMed.22943745.s1.e1" text="valproate" /><entity charOffset="104-116" id="DDI-PubMed.22943745.s1.e2" text="aripiprazole" /><pair ddi="false" e1="DDI-PubMed.22943745.s1.e0" e2="DDI-PubMed.22943745.s1.e0" /><pair ddi="false" e1="DDI-PubMed.22943745.s1.e0" e2="DDI-PubMed.22943745.s1.e1" /><pair ddi="false" e1="DDI-PubMed.22943745.s1.e0" e2="DDI-PubMed.22943745.s1.e2" /><pair ddi="false" e1="DDI-PubMed.22943745.s1.e1" e2="DDI-PubMed.22943745.s1.e1" /><pair ddi="false" e1="DDI-PubMed.22943745.s1.e1" e2="DDI-PubMed.22943745.s1.e2" /></sentence><sentence text="The antipsychotic, aripiprazole, plus lithium or valproate demonstrates rapid and significant improvement in manic symptoms that is sustained over the long term"><entity charOffset="19-31" id="DDI-PubMed.22943745.s2.e0" text="aripiprazole" /><entity charOffset="38-45" id="DDI-PubMed.22943745.s2.e1" text="lithium" /><entity charOffset="49-58" id="DDI-PubMed.22943745.s2.e2" text="valproate" /><pair ddi="false" e1="DDI-PubMed.22943745.s2.e0" e2="DDI-PubMed.22943745.s2.e0" /><pair ddi="false" e1="DDI-PubMed.22943745.s2.e0" e2="DDI-PubMed.22943745.s2.e1" /><pair ddi="false" e1="DDI-PubMed.22943745.s2.e0" e2="DDI-PubMed.22943745.s2.e2" /><pair ddi="false" e1="DDI-PubMed.22943745.s2.e1" e2="DDI-PubMed.22943745.s2.e1" /><pair ddi="false" e1="DDI-PubMed.22943745.s2.e1" e2="DDI-PubMed.22943745.s2.e2" /></sentence><sentence text=" A previous report showed that therapeutic doses of either lithium or valproate had no clinically significant effects on the pharmacokinetics of aripiprazole"><entity charOffset="59-66" id="DDI-PubMed.22943745.s3.e0" text="lithium" /><entity charOffset="70-79" id="DDI-PubMed.22943745.s3.e1" text="valproate" /><entity charOffset="145-157" id="DDI-PubMed.22943745.s3.e2" text="aripiprazole" /><pair ddi="false" e1="DDI-PubMed.22943745.s3.e0" e2="DDI-PubMed.22943745.s3.e0" /><pair ddi="false" e1="DDI-PubMed.22943745.s3.e0" e2="DDI-PubMed.22943745.s3.e1" /><pair ddi="false" e1="DDI-PubMed.22943745.s3.e0" e2="DDI-PubMed.22943745.s3.e2" /><pair ddi="false" e1="DDI-PubMed.22943745.s3.e1" e2="DDI-PubMed.22943745.s3.e1" /><pair ddi="false" e1="DDI-PubMed.22943745.s3.e1" e2="DDI-PubMed.22943745.s3.e2" /></sentence><sentence text=" We aimed to determine the effects of co-administration of aripiprazole on the steady-state pharmacokinetics of lithium or valproate in healthy subjects"><entity charOffset="59-71" id="DDI-PubMed.22943745.s4.e0" text="aripiprazole" /><entity charOffset="112-119" id="DDI-PubMed.22943745.s4.e1" text="lithium" /><entity charOffset="123-132" id="DDI-PubMed.22943745.s4.e2" text="valproate" /><pair ddi="false" e1="DDI-PubMed.22943745.s4.e0" e2="DDI-PubMed.22943745.s4.e0" /><pair ddi="false" e1="DDI-PubMed.22943745.s4.e0" e2="DDI-PubMed.22943745.s4.e1" /><pair ddi="false" e1="DDI-PubMed.22943745.s4.e0" e2="DDI-PubMed.22943745.s4.e2" /><pair ddi="false" e1="DDI-PubMed.22943745.s4.e1" e2="DDI-PubMed.22943745.s4.e1" /><pair ddi="false" e1="DDI-PubMed.22943745.s4.e1" e2="DDI-PubMed.22943745.s4.e2" /></sentence><sentence text="" /><sentence text="Two similarly designed, open-label, single-sequence studies were conducted" /><sentence text=" Healthy subjects received daily oral doses of either lithium (450 mg every 12 h) or valproate (500 mg every 12 h) on Days 1-7"><entity charOffset="54-61" id="DDI-PubMed.22943745.s7.e0" text="lithium" /><entity charOffset="85-94" id="DDI-PubMed.22943745.s7.e1" text="valproate" /><pair ddi="false" e1="DDI-PubMed.22943745.s7.e0" e2="DDI-PubMed.22943745.s7.e0" /><pair ddi="false" e1="DDI-PubMed.22943745.s7.e0" e2="DDI-PubMed.22943745.s7.e1" /></sentence><sentence text=" Following Day 7 was a 2-day washout period, and on Day 10, subjects began receiving oral doses of aripiprazole (10 mg once daily) for 2 days"><entity charOffset="99-111" id="DDI-PubMed.22943745.s8.e0" text="aripiprazole" /></sentence><sentence text=" Aripiprazole was then titrated from 10 to 20 mg once daily to establish tolerance of aripiprazole"><entity charOffset="1-13" id="DDI-PubMed.22943745.s9.e0" text="Aripiprazole" /><entity charOffset="86-98" id="DDI-PubMed.22943745.s9.e1" text="aripiprazole" /><pair ddi="false" e1="DDI-PubMed.22943745.s9.e0" e2="DDI-PubMed.22943745.s9.e0" /><pair ddi="false" e1="DDI-PubMed.22943745.s9.e0" e2="DDI-PubMed.22943745.s9.e1" /></sentence><sentence text=" On Day 14, the dose was escalated and subjects received aripiprazole 30 mg once daily for 13 days"><entity charOffset="57-69" id="DDI-PubMed.22943745.s10.e0" text="aripiprazole" /></sentence><sentence text=" Beginning on Day 20, subjects received lithium (450 mg every 12 h) or valproate (500 mg every 12 h) concomitantly with aripiprazole 30 mg once daily through Day 26"><entity charOffset="40-47" id="DDI-PubMed.22943745.s11.e0" text="lithium" /><entity charOffset="71-80" id="DDI-PubMed.22943745.s11.e1" text="valproate" /><entity charOffset="120-132" id="DDI-PubMed.22943745.s11.e2" text="aripiprazole" /><pair ddi="false" e1="DDI-PubMed.22943745.s11.e0" e2="DDI-PubMed.22943745.s11.e0" /><pair ddi="false" e1="DDI-PubMed.22943745.s11.e0" e2="DDI-PubMed.22943745.s11.e1" /><pair ddi="false" e1="DDI-PubMed.22943745.s11.e0" e2="DDI-PubMed.22943745.s11.e2" /><pair ddi="false" e1="DDI-PubMed.22943745.s11.e1" e2="DDI-PubMed.22943745.s11.e1" /><pair ddi="false" e1="DDI-PubMed.22943745.s11.e1" e2="DDI-PubMed.22943745.s11.e2" /></sentence><sentence text=" Serial blood samples for serum lithium or valproate concentration determination were collected for up to 12 h post-lithium or valproate administration on Days 7 and 26"><entity charOffset="32-39" id="DDI-PubMed.22943745.s12.e0" text="lithium" /><entity charOffset="43-52" id="DDI-PubMed.22943745.s12.e1" text="valproate" /><entity charOffset="127-136" id="DDI-PubMed.22943745.s12.e2" text="valproate" /><pair ddi="false" e1="DDI-PubMed.22943745.s12.e0" e2="DDI-PubMed.22943745.s12.e0" /><pair ddi="false" e1="DDI-PubMed.22943745.s12.e0" e2="DDI-PubMed.22943745.s12.e1" /><pair ddi="false" e1="DDI-PubMed.22943745.s12.e0" e2="DDI-PubMed.22943745.s12.e2" /><pair ddi="false" e1="DDI-PubMed.22943745.s12.e1" e2="DDI-PubMed.22943745.s12.e1" /><pair ddi="false" e1="DDI-PubMed.22943745.s12.e1" e2="DDI-PubMed.22943745.s12.e2" /></sentence><sentence text="" /><sentence text="The lithium study enrolled 32 healthy subjects (72% completed the study), and the valproate study enrolled 48 healthy subjects (58% completed the study)"><entity charOffset="4-11" id="DDI-PubMed.22943745.s14.e0" text="lithium" /><entity charOffset="82-91" id="DDI-PubMed.22943745.s14.e1" text="valproate" /><pair ddi="false" e1="DDI-PubMed.22943745.s14.e0" e2="DDI-PubMed.22943745.s14.e0" /><pair ddi="false" e1="DDI-PubMed.22943745.s14.e0" e2="DDI-PubMed.22943745.s14.e1" /></sentence><sentence text=" In both studies, the 90% confidence intervals for the ratios of population geometric means, with and without aripiprazole, were contained within 80% and 125% for both the C(max) and AUC(τ) , respectively"><entity charOffset="110-122" id="DDI-PubMed.22943745.s15.e0" text="aripiprazole" /></sentence><sentence text=" Furthermore, the addition of aripiprazole did not change the median T(max) of lithium or valproate (4 h)"><entity charOffset="30-42" id="DDI-PubMed.22943745.s16.e0" text="aripiprazole" /><entity charOffset="79-86" id="DDI-PubMed.22943745.s16.e1" text="lithium" /><entity charOffset="90-99" id="DDI-PubMed.22943745.s16.e2" text="valproate" /><pair ddi="false" e1="DDI-PubMed.22943745.s16.e0" e2="DDI-PubMed.22943745.s16.e0" /><pair ddi="false" e1="DDI-PubMed.22943745.s16.e0" e2="DDI-PubMed.22943745.s16.e1" /><pair ddi="false" e1="DDI-PubMed.22943745.s16.e0" e2="DDI-PubMed.22943745.s16.e2" /><pair ddi="false" e1="DDI-PubMed.22943745.s16.e1" e2="DDI-PubMed.22943745.s16.e1" /><pair ddi="false" e1="DDI-PubMed.22943745.s16.e1" e2="DDI-PubMed.22943745.s16.e2" /></sentence><sentence text=" Thus, the addition of aripiprazole did not affect the steady-state pharmacokinetics of lithium or valproate"><entity charOffset="23-35" id="DDI-PubMed.22943745.s17.e0" text="aripiprazole" /><entity charOffset="88-95" id="DDI-PubMed.22943745.s17.e1" text="lithium" /><entity charOffset="99-108" id="DDI-PubMed.22943745.s17.e2" text="valproate" /><pair ddi="false" e1="DDI-PubMed.22943745.s17.e0" e2="DDI-PubMed.22943745.s17.e0" /><pair ddi="false" e1="DDI-PubMed.22943745.s17.e0" e2="DDI-PubMed.22943745.s17.e1" /><pair ddi="false" e1="DDI-PubMed.22943745.s17.e0" e2="DDI-PubMed.22943745.s17.e2" /><pair ddi="false" e1="DDI-PubMed.22943745.s17.e1" e2="DDI-PubMed.22943745.s17.e1" /><pair ddi="false" e1="DDI-PubMed.22943745.s17.e1" e2="DDI-PubMed.22943745.s17.e2" /></sentence><sentence text=" The majority of subjects (76·9% for aripiprazole plus lithium and 68·4% for aripiprazole plus valproate) reported adverse events, but this adverse event profile is consistent with what has been observed in other studies"><entity charOffset="37-49" id="DDI-PubMed.22943745.s18.e0" text="aripiprazole" /><entity charOffset="55-62" id="DDI-PubMed.22943745.s18.e1" text="lithium" /><entity charOffset="77-89" id="DDI-PubMed.22943745.s18.e2" text="aripiprazole" /><entity charOffset="95-104" id="DDI-PubMed.22943745.s18.e3" text="valproate" /><pair ddi="false" e1="DDI-PubMed.22943745.s18.e0" e2="DDI-PubMed.22943745.s18.e0" /><pair ddi="false" e1="DDI-PubMed.22943745.s18.e0" e2="DDI-PubMed.22943745.s18.e1" /><pair ddi="false" e1="DDI-PubMed.22943745.s18.e0" e2="DDI-PubMed.22943745.s18.e2" /><pair ddi="false" e1="DDI-PubMed.22943745.s18.e0" e2="DDI-PubMed.22943745.s18.e3" /><pair ddi="false" e1="DDI-PubMed.22943745.s18.e1" e2="DDI-PubMed.22943745.s18.e1" /><pair ddi="false" e1="DDI-PubMed.22943745.s18.e1" e2="DDI-PubMed.22943745.s18.e2" /><pair ddi="false" e1="DDI-PubMed.22943745.s18.e1" e2="DDI-PubMed.22943745.s18.e3" /><pair ddi="false" e1="DDI-PubMed.22943745.s18.e2" e2="DDI-PubMed.22943745.s18.e2" /><pair ddi="false" e1="DDI-PubMed.22943745.s18.e2" e2="DDI-PubMed.22943745.s18.e3" /></sentence><sentence text="" /><sentence text="The addition of aripiprazole to either lithium or valproate had no clinically meaningful effects on the pharmacokinetics of either drug"><entity charOffset="16-28" id="DDI-PubMed.22943745.s20.e0" text="aripiprazole" /><entity charOffset="39-46" id="DDI-PubMed.22943745.s20.e1" text="lithium" /><entity charOffset="50-59" id="DDI-PubMed.22943745.s20.e2" text="valproate" /><pair ddi="false" e1="DDI-PubMed.22943745.s20.e0" e2="DDI-PubMed.22943745.s20.e0" /><pair ddi="false" e1="DDI-PubMed.22943745.s20.e0" e2="DDI-PubMed.22943745.s20.e1" /><pair ddi="false" e1="DDI-PubMed.22943745.s20.e0" e2="DDI-PubMed.22943745.s20.e2" /><pair ddi="false" e1="DDI-PubMed.22943745.s20.e1" e2="DDI-PubMed.22943745.s20.e1" /><pair ddi="false" e1="DDI-PubMed.22943745.s20.e1" e2="DDI-PubMed.22943745.s20.e2" /></sentence><sentence text=" In addition, co-administration of aripiprazole with lithium or valproate demonstrated no unexpected safety signals in healthy subjects"><entity charOffset="35-47" id="DDI-PubMed.22943745.s21.e0" text="aripiprazole" /><entity charOffset="53-60" id="DDI-PubMed.22943745.s21.e1" text="lithium" /><entity charOffset="64-73" id="DDI-PubMed.22943745.s21.e2" text="valproate" /><pair ddi="false" e1="DDI-PubMed.22943745.s21.e0" e2="DDI-PubMed.22943745.s21.e0" /><pair ddi="false" e1="DDI-PubMed.22943745.s21.e0" e2="DDI-PubMed.22943745.s21.e1" /><pair ddi="false" e1="DDI-PubMed.22943745.s21.e0" e2="DDI-PubMed.22943745.s21.e2" /><pair ddi="false" e1="DDI-PubMed.22943745.s21.e1" e2="DDI-PubMed.22943745.s21.e1" /><pair ddi="false" e1="DDI-PubMed.22943745.s21.e1" e2="DDI-PubMed.22943745.s21.e2" /></sentence><sentence text="" /></document>